Description
Nilotinib hydrochlorid is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.
Molecular Formula
C28H23ClF3N7O
Standard
CP/EP/USP/In-house
Facility GMP
Preparation Use
In treatment of chronic myelogenous leukemia. It is a COVID19-related research product.
Qualification
DMF/CEP/EMA